Why Nano-X Imaging Ltd.’s (NNOX) Stock Is Down 5.32%
As of Thursday, September 10, Nano-X Imaging Ltd.’s NNOX share price has dipped by 5.32%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company’s solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligence–based solution; AI-Based Body Composition Measurement, an artificial intelligence–based body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.
Commentary & Analysis
Why Nano-X Imaging Ltd.’s (NNOX) Stock Is Up 6.25%
As of Friday, July 17, Nano-X Imaging Ltd.’s NNOX share price has surged by 6.25%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why Nano-X Imaging Ltd.’s (NNOX) Stock Is Down 5.13%
As of Friday, July 10, Nano-X Imaging Ltd.’s NNOX share price has dipped by 5.13%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Why Nano-X Imaging Ltd.’s (NNOX) Stock Is Down 8.71%
As of Tuesday, July 07, Nano-X Imaging Ltd.’s NNOX share price has dipped by 8.71%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Why Nano-X Imaging Ltd.’s (NNOX) Stock Is Up 5.38%
As of Monday, July 06, Nano-X Imaging Ltd.’s NNOX share price has surged by 5.38%, which has investors questioning if this is right time to sell.Michael Rose
Financial Summary
| Share Statistics | NNOX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $36.1 | $1,704.9 | 14% |
|
| Shares Out (Mil) | 69.9 | 80.1 | 55% |
|
| Institutional Ownership | 67.5% | 86.9% | 42% |
|
| Float (Mil) | 64.3 | 56.2 | 52% |
|
| Beta | 1.25 | 0.78 | 73% |
|
| Avg Daily Volume (000s) | 814 | 543 | 66% |
|
| Price Change (52-week) |
(86.8%) | 78.1% | 6% |
|
| Growth | NNOX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 10.4% | na |
|
| Net Income (5yr) | (11.4%) | (0.5%) | 28% |
|
| EPS (5yr) | 1.2% | 2.1% | 33 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | (51.8%) | (17.1%) | 6% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | ($0.140) | ($0.600) | ($0.400) | |
| Month Ago EPS | ($0.140) | ($0.600) | ($0.400) | |
| # Rev Up | 1 | 0 | 0 | |
| # Rev Down | 0 | 1 | 1 | |
| Three Months Ago EPS | ($0.100) | ($0.480) | ($0.300) | |
| Year/Year Chg | (82.3%) | (48.2%) | (74.1%) | |
| Financials | NNOX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $16 | $1,504 | 11% |
|
| Net Income (TTM) (Mil) | ($117) | $24 | 10% |
|
| EPS (TTM) | ($1.724) | $0.200 | 16% |
|
| Operating Cash Flow (TTM) (Mil) | ($47) | $162 | 10% |
|
| Net Cash Flow (TTM) (Mil) | $2 | $2 | 48% |
|
| Long-Term Debt (Q1) (Mil) | $4 | $375 | 23% |
|
| Enterprise Value (Q1) (Mil) | $26 | $2,238 | 12% |
|
| Valuation | NNOX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.50 | 2.95 | 9% |
|
| P/E | na | 25.9 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | NNOX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (77.2%) | 27.4% | 2% |
|
| Net Margin | (747.2%) | 1.2% | 1% |
|
| ROA | (81.4%) | 2.0% | 7% |
|
| ROE | (94.4%) | 6.8% | 10% |
|
| Liabilities to Assets | 20.5% | 61.0% | 13% |
|
| F-Score | 3 | 5 | 18% |
|
Nano-X Imaging Ltd. did not pass any screens on 10/13/2026.
